The association between BMI and hospitalization for heart failure in 83 021 persons with Type 2 diabetes: A population-based study from the Swedish National Diabetes Registry

Diabetic Medicine

Volumn 31, Issue 5, 2014, Pages 586-594

  Glogner, S ^a   Rosengren, A ^b   Olsson, M ^c   Gudbjornsdottir S ^b   Svensson, A M ^d   Lind, M ^b,e  

^a Department of Oral and Maxillofacial Surgery Otolaryngology   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c CHALMERS UNIVERSITY OF TECHNOLOGY   (Sweden)

^d Center of Registers in Region Vastra Götaland   (Sweden)

^e NU Hospital Organization   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; BODY MASS; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE REGISTRY; FEMALE; FOLLOW UP; HEART FAILURE; HOSPITALIZATION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; MORBIDITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; SMOKING; SWEDEN; SYSTOLIC BLOOD PRESSURE; COMPLICATION; DIABETES MELLITUS, TYPE 2; EPIDEMIOLOGY; LONGITUDINAL STUDY; MIDDLE AGED; MORTALITY; PREVALENCE; REGISTER; REGRESSION ANALYSIS; RISK FACTOR; SEX DIFFERENCE; STATISTICS AND NUMERICAL DATA; SURVIVAL RATE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HOSPITALIZATION; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; OBESITY; PREVALENCE; REGISTRIES; REGRESSION ANALYSIS; RISK FACTORS; SEX FACTORS; SURVIVAL RATE; SWEDEN;

EID: 84898870836     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/dme.12340     Document Type: Article

References (20)

1. Whiting DR, Guariguata L, Weil C, Shaw J. IDF Diabetes Atlas: Global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract 2011; 94: 311-321.
2. Roger VL, Go AS, Lloyd-Jones DM, Benjamin EJ, Berry JD, Borden WB et al. Heart disease and stroke statistics-2012 update: a report from the American Heart Association. Circulation 2012; 125: e2-e220.
3. Nichols GA, Gullion CM, Koro CE, Ephross SA, Brown JB. The incidence of congestive heart failure in type 2 diabetes: an update. Diabetes Care 2004; 27: 1879-1884.
4. Lind M, Olsson M, Rosengren A, Svensson A-M, Bounias I, Gudbjörnsdottir S. The relationship between glycaemic control and heart failure in 83, 021 patients with Type 2 diabetes. Diabetologia 2012; 55: 2946-2953.
5. Turnbull FM, Abraira C, Anderson RJ, Byington RP, Chalmers JP, Duckworth WC et al. Intensive glucose control and macrovascular outcomes in type 2 diabetes. Diabetologia 2009; 52: 2288-2298.
6. Kannel WB, McGee DL. Diabetes and glucose tolerance as risk factors for cardiovascular disease: the Framingham study. Diabetes Care 1979; 2: 120-126.
7. American Diabetes Association. Standards of medical care in diabetes-2012. Diabetes Care 2012; 35: S11-63.
8. Kenchaiah S, Evans JC, Levy D, Wilson PWF, Benjamin EJ, Larson MG et al. Obesity and the risk of heart failure. N Engl J Med 2002; 347: 305-313.
9. Adamopoulos C, Meyer P, Desai RV, Karatzidou K, Ovalle F, White M et al. Absence of obesity paradox in patients with chronic heart failure and diabetes mellitus: a propensity-matched study. Eur J Heart Fail 2011; 13: 200-206.
10. Schmiegelow M, Andersson C, Olesen JB, Abildstrom SZ, Kober L, Torp-Pedersen C. Body mass index is closely correlated to incident diabetes in patients with heart failure or myocardial infarction. Eur J Cardiovasc Prev Rehabil 2011; 18: 305-311.
11. Lind M, Bounias I, Olsson M, Gudbjörnsdottir S, Svensson A-M, Rosengren A. Glycaemic control and incidence of heart failure in 20, 985 patients with type 1 diabetes: an observational study. Lancet 2011; 378: 140-146.
12. Cederholm J, Eeg-Olofsson K, Eliasson B, Zethelius B, Nilsson PM, Gudbjörnsdottir S. Risk prediction of cardiovascular disease in type 2 diabetes: a risk equation from the Swedish National Diabetes Register. Diabetes Care 2008; 31: 2038-2043.
13. Shafazand M, Schaufelberger M, Lappas G, Swedberg K, Rosengren A. Survival trends in men and women with heart failure of ischaemic and non-ischaemic origin: data for the period 1987-2003 from the Swedish Hospital Discharge Registry. Eur Heart J 2009; 30: 671-678.
14. Ingelsson E, Arnlöv J, Sundström J, Lind L. The validity of a diagnosis of heart failure in a hospital discharge register. Eur J Heart Fail 2005; 7: 787-791.
15. Stratton IM, Cull CA, Adler AI, Matthews DR, Neil HAW, Holman RR. Additive effects of glycaemia and blood pressure exposure on risk of complications in type 2 diabetes: a prospective observational study (UKPDS 75). Diabetologia 2006; 49: 1761-1769.
16. Eeg-Olofsson K, Cederholm J, Nilsson PM, Zethelius B, Nunez L, Gudbjörnsdóttir S et al. Risk of cardiovascular disease and mortality in overweight and obese patients with type 2 diabetes: an observational study in 13, 087 patients. Diabetologia 2009; 52: 65-73.
17. Wing RR. Long-term effects of a lifestyle intervention on weight and cardiovascular risk factors in individuals with type 2 diabetes mellitus: four-year results of the Look AHEAD trial. Arch Intern Med 2010; 170: 1566-1575.
18. Jendle J, Torffvit O, Ridderstråle M, Lammert M, Ericsson A, Bøgelund M. Willingness to pay for health improvements associated with anti-diabetes treatments for people with type 2 diabetes. Curr Med Res Opin 2010; 26: 917-923.
19. Inzucchi SE, Bergenstal RM, Buse JB, Diamant M, Ferrannini E, Nauck M et al. Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia 2012; 55: 1577-1596.
20. Lind M. Incretin therapy and its effect on body weight in patients with diabetes. Prim Care Diabetes 2012; 6: 187-191.